STOCK TITAN

SYNCHRONY FINANCIAL Form 4 Filings

SYF NYSE

Every Form 4 that SYNCHRONY FINANCIAL (SYF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SYF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SYF filings page.

Rhea-AI Summary

COLAO DANIEL O reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Daniel O. Colao received a grant of 14 Dividend Equivalent Units on May 15, 2026. These units were accrued as dividends on common shares underlying his restricted stock units at a reference value of $71.38 per unit.

The dividend equivalent units vest proportionately with, and are subject to the same settlement and expiration terms as, the related restricted stock units. Each unit is the economic equivalent of one share of Synchrony Financial common stock. Following this grant, Colao directly holds 4,883 such units.

Rhea-AI Summary

Synchrony Financial officer Bart Schaller reported a compensation-related grant on a Form 4. He acquired 143 dividend equivalent units on May 15, 2026, tied to dividends paid on common shares underlying his restricted stock units at a reference value of $71.38 per unit.

These dividend equivalent units vest and settle on the same terms and schedule as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock. Following this grant, Schaller directly holds 34,178 dividend equivalent units.

Rhea-AI Summary

NAYLOR JEFFREY G reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Jeffrey G. Naylor received 197 dividend equivalent units tied to prior equity awards. These units accrued on May 15, 2026 as dividends on common shares underlying restricted stock units and deferred stock units granted under company incentive and director compensation plans. Each dividend equivalent unit is economically equal to one share of Synchrony common stock. Following this grant, Naylor directly holds 64,217 dividend equivalent units, reflecting a routine, non-market, compensation-related increase in his position.

Rhea-AI Summary

Zane Ellen M reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Ellen M. Zane received a grant of 14 dividend equivalent units on May 15, 2026. These units were accrued as dividends on common shares underlying her restricted stock units at a reference price of $71.38 per unit. After this compensation-related award, she directly holds 31,440 units, each economically equivalent to one share of Synchrony common stock, and the new units vest and settle on the same terms as the related restricted stock units.

Rhea-AI Summary

Synchrony Financial executive Jonathan S. Mothner reported an exercise-and-sale transaction in company stock. On May 15, 2026, he exercised 11,258 employee stock options at $34.30 per share and sold a total of 51,258 common shares at $71.23 per share in open-market sales.

The sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he directly holds 132,664 shares of Synchrony common stock. He also acquired 217 dividend equivalent units, which track the value of Synchrony stock and vest on the same schedule as related restricted stock units.

Rhea-AI Summary

Parker P.W. reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director P.W. Parker reported a routine compensation-related award. On May 15, 2026, Parker received 14 dividend equivalent units at $71.38 each, accrued on dividends paid on common shares underlying restricted stock units. These units vest and settle on the same schedule as the related restricted stock units, and each represents the economic equivalent of one Synchrony common share. Following this grant, Parker directly holds 33,686 units.

Rhea-AI Summary

Alves Paget Leonard reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Paget Leonard Alves received a small compensation-related award rather than buying shares on the market. On May 15, 2026, Alves was granted 153 dividend equivalent units at an assigned value of $71.38 per unit. These units were accrued as dividends on previously granted restricted stock units and deferred stock units under Synchrony’s long-term incentive and non-employee director deferred compensation plans. Each dividend equivalent unit is economically equivalent to one share of Synchrony Financial common stock, bringing Alves’s directly held units and related share-equivalents to 51,594 following this accrual.

Rhea-AI Summary

Richie Laurel reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Laurel Richie received a grant of 135 dividend equivalent units on May 15, 2026. These units were accrued as dividends on common shares underlying previously granted restricted and deferred stock units, at an economic value of $71.38 per unit. Following this compensation-related award, Richie directly holds 50,902 units/shares-equivalent of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial officer Curtis Howse reported an open-market sale of 8,436 shares of Synchrony Financial common stock on May 1, 2026 at $76.55 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on July 24, 2025. After this transaction, Howse directly holds 86,437 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director Arthur W. Coviello Jr. reported an open-market sale of 4,000 shares of Common Stock at an average price of $76.55 per share. After this transaction, he directly holds 29,341 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 25, 2025, indicating the trade was scheduled in advance.

Rhea-AI Summary

Synchrony Financial officer Alberto Casellas exercised stock options and sold the resulting shares in a planned trade. On May 1, he exercised options to acquire 5,794 shares of common stock at $34.30 per share, then sold 5,794 shares in an open‑market transaction at $76.55 per share.

The filing shows these transactions were executed under a pre‑arranged Rule 10b5‑1 trading plan adopted on October 27, 2025. Following the sale, Casellas directly holds 50,331 shares of Synchrony common stock, and the 2017 option grant for 11,588 shares has been fully exercised.

Rhea-AI Summary

Synchrony Financial director Alves Paget Leonard received an equity award of 883 shares of Common Stock, reported at $68.02 per share. The award is in the form of restricted stock units that will vest in full on March 31, 2027, each converting into one share of Synchrony Financial common stock. Following this grant, Leonard’s direct holdings total 51,441 shares, reflecting a routine, compensation-related increase in ownership rather than an open‑market purchase.

Rhea-AI Summary

GUTHRIE ROY A reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Roy A. Guthrie received a grant of 883 restricted stock units of common stock at $68.02 per share-equivalent. These restricted stock units will vest in full on March 31, 2027, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.

After this grant, Guthrie directly holds 39,763 shares of common stock. Separately, Guthrie 2012 Investments LP owns 34,106 shares of common stock; Guthrie serves as Investment Manager of this partnership and disclaims beneficial ownership of those shares except to the extent of his direct pecuniary interest.

Rhea-AI Summary

Synchrony Financial director Jeffrey G. Naylor received an equity award of 1,343 shares of common stock in the form of restricted stock units. The award is valued at $68.02 per share on the grant date and increases his direct holdings to 64,020 shares.

The restricted stock units will vest in full on March 31, 2027, at which time each unit will convert into one share of Synchrony Financial common stock if the vesting conditions are met. This is a compensation-related, non-market acquisition rather than an open-market purchase.

Rhea-AI Summary

Synchrony Financial director Daniel O. Colao received an equity award of 883 restricted stock units of common stock. The award is classified as a grant or other acquisition, not an open-market purchase, at a reference price of $68.02 per share.

The restricted stock units will vest in full on March 31, 2027, at which time each unit will convert into one share of Synchrony Financial common stock if vesting conditions are met. Following this award, Colao directly holds 4,869 shares of common stock, reflecting a routine compensation-related increase in his equity stake.

Rhea-AI Summary

AGUIRRE FERNANDO reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Fernando Aguirre received a grant of 883 restricted stock units, each representing one share of common stock. These restricted stock units are scheduled to vest in full on March 31, 2027. Following this award, Aguirre directly holds 29,459 common shares and also reports indirect ownership of 15,300 shares through family trusts.

Rhea-AI Summary

Zane Ellen M reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Ellen M. Zane received an equity award of 883 restricted stock units of common stock. The units were valued at $68.02 per share for reporting purposes and are scheduled to vest in full on March 31, 2027, assuming conditions are met.

Each restricted stock unit represents a contingent right to receive one Synchrony Financial common share. After this grant, Zane’s reported direct holdings total 31,426 shares, reflecting a routine, compensation-related award rather than an open-market purchase.

Rhea-AI Summary

ELLINGER DEBORAH G reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Deborah G. Ellinger received an award of 883 shares of common stock in the form of restricted stock units. The award is valued at $68.02 per share and increases her direct holdings to 1,546 shares of Synchrony Financial common stock.

The restricted stock units will vest in full on March 31, 2027. Each unit represents a contingent right to receive one share of Synchrony Financial common stock, meaning Ellinger will receive the underlying shares only if the vesting conditions are satisfied.

Rhea-AI Summary

Chytil Kamila K reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Kamila K. Chytil received an award of 883 shares of common stock in the form of restricted stock units. The units are valued at $68.02 per share and will vest in full on March 31, 2027, reflecting compensation rather than an open-market purchase.

After this grant, Chytil directly holds 17,115 shares of Synchrony Financial common stock, including this new award. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.

Rhea-AI Summary

COVIELLO ARTHUR W JR reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Arthur W. COVIELLO JR received an equity grant of 883 shares of common stock on March 31, 2026 as a grant or award. The grant is in the form of restricted stock units valued at $68.02 per share and will vest in full on March 31, 2027.

Each restricted stock unit represents a right to receive one share of Synchrony Financial common stock once vesting conditions are met. After this award, the director directly holds 33,341 shares of Synchrony Financial common stock.

Rhea-AI Summary

Richie Laurel reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Richie Laurel received a grant of restricted stock units, not an open-market share purchase. The award covers 883 units of common stock valued at $68.02 per unit on the grant date. Following this grant, Laurel holds 50,767 shares directly.

The 883 restricted stock units will vest in full on March 31, 2027, meaning shares are delivered only if the vesting conditions are met. Each unit represents a contingent right to receive one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director P.W. Parker received an equity grant of 883 shares of common stock in the form of restricted stock units. These units were valued at $68.02 per share for reporting purposes and will vest in full on March 31, 2027.

Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. After this award, Parker directly holds 33,672 shares, reflecting a routine compensation-related acquisition rather than an open-market purchase.

Rhea-AI Summary

Synchrony Financial insider Courtney Gentleman reported several common stock transactions. On March 1, 2026, Gentleman received a grant of 9,768 restricted stock units at $69.11 per share value, which will vest in three equal annual installments of 33.33% beginning on the first anniversary of the grant date.

Also on March 1, 3,452 shares of Synchrony Financial common stock were withheld by the company to cover tax liabilities arising from restricted stock unit vesting. On March 2, 2026, Gentleman executed an open-market sale of 4,338 shares at an average price of $67.71 per share under a pre-established Rule 10b5-1 trading plan adopted on November 5, 2025.

Following these transactions, Gentleman directly owned 19,831 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial officer Bart Schaller reported several stock transactions. On March 1, 2026, he received a grant of 14,610 restricted stock units at $69.11 per share. These units vest in three equal annual installments of 33.33% each, starting one year after the grant date.

Also on March 1, 9,895 shares of common stock were automatically withheld at $69.11 to cover taxes due on vesting; no investment decision was made for this tax-withholding disposition. On March 2, 2026, he executed an open-market sale of 12,980 shares at $67.71 per share under a pre-established Rule 10b5-1 trading plan, leaving 34,035 shares of common stock held directly after the sale.

Rhea-AI Summary

Synchrony Financial officer Carol Juel reported multiple stock transactions involving company common shares. On March 2, 2026, she completed an open-market sale of 16,859 shares at $67.71 per share under a pre-arranged Rule 10b5-1 trading plan, leaving her with 51,446 directly owned shares after that transaction.

On March 1, 2026, she acquired 24,093 shares through a restricted stock unit grant at a reference price of $69.11 per share. These units vest in three equal annual installments of 33.33%, each representing the right to receive one share. Also on March 1, 14,561 shares were withheld by Synchrony to cover tax liabilities upon vesting, described as a tax-withholding disposition with no investment decision by Juel.

Rhea-AI Summary

Synchrony Financial executive Curtis Howse reported several stock transactions involving company common shares. On March 2, 2026, he completed an open-market sale of 7,882 shares at an average price of $67.71 per share, leaving him with 94,873 directly held shares afterward.

On March 1, 2026, he received a grant of 19,535 restricted stock units at $69.11 per share, which will vest in three equal annual installments of 33.33% beginning one year after the grant date. Also on that date, 11,184 shares were automatically withheld by the company to cover tax liabilities tied to vesting, with no investment decision by Howse. The sale was executed under a Rule 10b5-1 trading plan adopted on July 24, 2025.

Rhea-AI Summary

Synchrony Financial executive Jonathan S. Mothner reported two equity transactions involving company common stock. On March 1, 2026, 12,936 shares were automatically withheld at $69.11 per share to cover his tax liability upon the vesting of restricted stock units, and no investment decision was made by him in connection with this tax-withholding disposition.

On the same date, he received a grant of 24,093 restricted stock units at $69.11 per share, which will vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date. Following these transactions, his directly held common stock increased to 172,447 shares.

Rhea-AI Summary

Synchrony Financial officer Darrell Owens reported multiple stock transactions involving company common shares. He received a grant of 8,140 restricted stock units at $69.11 per share, which will vest in three equal annual installments, each unit representing one future share.

To cover taxes on vesting, 3,076 shares were withheld by the company. Owens then sold 3,865 shares of common stock in an open-market transaction at $67.71 per share under a Rule 10b5-1 trading plan adopted on October 17, 2025. After these moves, he directly owned 17,432 shares.

Rhea-AI Summary

Synchrony Financial officer Amy Tiliakos reported equity compensation activity involving company common stock. On March 1, 2026, she acquired 3,907 restricted stock units at a reference price of $69.11 per share as a grant, award, or other acquisition.

The filing notes these restricted stock units vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date, with each unit representing a contingent right to receive one share of common stock. On the same date, 335 shares of common stock were disposed of at $69.11 per share to cover tax liabilities from vesting, through automatic withholding by Synchrony Financial, and the filing specifies that no investment decision was made by the reporting person for this tax-withholding transaction.

Rhea-AI Summary

Synchrony Financial officer Brian J. Wenzel Sr. reported multiple transactions in Company common stock. On March 1, 2026, he received a grant of 31,255 restricted stock units at $69.11 per share, which will vest in three equal annual installments of 33.33% each.

Also on March 1, 16,911 shares were automatically withheld at $69.11 to cover tax liabilities upon vesting of restricted stock units, with no investment decision by him. On March 2, he executed an open-market sale of 19,580 shares at $67.71 per share, followed by another open-market sale of 47,112 shares at $67.16 per share on March 3, all under a pre-established Rule 10b5-1 trading plan adopted on October 31, 2025.

Rhea-AI Summary

Synchrony Financial executive Alberto Casellas reported a mix of equity award activity, tax withholding, and a pre-planned stock sale. He received a grant of 19,535 restricted stock units at $69.11 per unit, which will vest in three equal annual installments of 33.33% each, starting on the first anniversary of the grant date.

To cover taxes on vesting restricted stock units, 12,143 shares of common stock were withheld by the company at $69.11 per share. Casellas also executed an open-market sale of 14,399 shares of common stock at $67.71 per share under a Rule 10b5-1 trading plan adopted on October 27, 2025, and continued to hold directly owned shares after these transactions.

Rhea-AI Summary

Synchrony Financial director and officer Brian D. Doubles reported multiple equity transactions. On March 1–2, 2026, he exercised employee stock options for 39,105 and 28,449 shares and received a grant of 105,322 shares of common stock at $69.11 per share. The company automatically withheld 68,158 shares to cover tax obligations tied to restricted stock vesting, with no investment decision by Doubles. He then sold 150,000, 39,105, and 28,449 shares of common stock in open‑market transactions at weighted average prices of $68.86, $68.52, and $67.96, respectively, including sales under a Rule 10b5‑1 trading plan adopted on October 27, 2025. After these transactions, Doubles directly owned 829,222 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director Jeffrey G. Naylor reported an acquisition of dividend equivalent units linked to prior equity awards. On February 17, 2026, he received 190 dividend equivalent units at an assigned value of $72.3100 per unit, bringing his directly held units and related shares to 62,677.

These dividend equivalent units were credited as dividends on common shares underlying restricted stock units and deferred stock units previously granted under Synchrony’s long-term incentive and non-employee director deferred compensation plans. Each unit is economically equivalent to one share of Synchrony Financial common stock, increasing the director’s incentive-based exposure without an open-market purchase.

Rhea-AI Summary

Synchrony Financial director reports a routine equity-related award. Director Daniel O. Colao acquired 14 dividend equivalent units on February 17, 2026 at a reference price of $72.31 per unit. After this grant, he holds 3,986 dividend equivalent units directly.

The footnote explains these units were accrued as dividends on common shares underlying restricted stock units. The dividend equivalent units vest proportionately with the related restricted stock units and follow the same settlement and expiration terms. Each unit is the economic equivalent of one share of Synchrony Financial common stock, providing additional stock-linked compensation tied to existing awards.

Rhea-AI Summary

Synchrony Financial executive Carol Juel reported mixed insider activity involving company equity on February 17, 2026. She received 243 dividend equivalent units tied to restricted stock units, each economically equal to one common share, reflecting dividends on underlying awards. On the same date, she sold 44,411 shares of Synchrony Financial common stock in an open-market transaction at a reported price of $70.60 per share under a pre-established Rule 10b5-1 trading plan. Following these transactions, her directly held common stock position was 58,773 shares, and her dividend equivalent unit balance was 103,184 units.

Rhea-AI Summary

Synchrony Financial director Ellen M. Zane reported an acquisition of 14 dividend equivalent units on February 17, 2026. These units were accrued as dividends on common shares underlying restricted stock units and are valued at 72.3100 per unit. After this grant, she directly holds a total of 30,543 dividend equivalent units. The units vest proportionately with the related restricted stock units and settle or expire on the same terms, and each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial officer Courtney Gentleman reported mixed insider activity. On February 17, 2026, she received a grant of 74 dividend equivalent units tied to existing restricted stock units, each economically equal to one share of Synchrony common stock. The same day, she executed an open-market sale of 12,045 common shares at $70.60 per share under a pre-established Rule 10b5-1 trading plan adopted on November 5, 2025.

Following these transactions, she directly held 17,853 shares of Synchrony common stock and 29,898 dividend equivalent units, which vest and settle on the same terms as their underlying restricted stock units.

Rhea-AI Summary

Synchrony Financial officer Alberto Casellas reported multiple equity transactions involving company stock and related units. On February 17, 2026, he acquired 5,794 Employee Stock Options through an exercise of derivative securities and received 208 dividend equivalent units tied to restricted stock units, plus 0.76 phantom stock units through a deferred compensation dividend reinvestment feature.

He also acquired 5,794 shares of common stock upon option exercise at a stated exercise price of $34.30 per share, then sold 41,514 shares of common stock in an open-market transaction at $70.60 per share under a pre-established Rule 10b5-1 trading plan. Following these transactions, he directly held 57,338 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director Deborah G. Ellinger reported an automatic award of dividend equivalent units. On this Form 4, she acquired 3.000 dividend equivalent units at a reference price of $72.31 per unit, increasing her directly held balance to 663.000 units.

The footnote explains these units were accrued as dividends on common shares underlying restricted stock units. They vest and settle on the same schedule as the related restricted stock units, and each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director Kamila K. Chytil reported an automatic award of dividend equivalent units. On February 17, 2026, she acquired 14 dividend equivalent units at an indicated price of $72.31 per unit, bringing her directly held balance to 16,232 units. These units were accrued as dividends on common shares underlying restricted stock units and will vest, settle, and expire on the same terms as the related restricted stock units. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

MOTHNER JONATHAN S reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial executive Jonathan S. Mothner received additional stock-based compensation through dividend equivalent units. On February 17, 2026, he was granted 233 dividend equivalent units tied to dividends paid on common shares underlying his restricted stock units, at a reference price of $72.31 per share. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock. Following this grant, Mothner directly holds 161,290 units/shares in total.

Rhea-AI Summary

Synchrony Financial officer Bart Schaller reported both an equity award and a share sale. On February 17, 2026, he acquired 175 dividend equivalent units tied to existing restricted stock units, each economically equal to one share of Synchrony common stock and vesting on the same schedule.

On the same date, he sold 35,300 shares of Synchrony common stock in an open-market transaction at $70.60 per share under a pre-arranged Rule 10b5-1 trading plan adopted on October 29, 2025. Following these transactions, he directly held 77,600 dividend equivalent units and 42,300 common shares.

Rhea-AI Summary

Synchrony Financial director Arthur W. Coviello Jr reported an automatic acquisition of 14 dividend equivalent units on February 17, 2026. These units were accrued as dividends on common shares underlying his restricted stock units, at a reference value of $72.31 per unit. After this grant, his directly held dividend equivalent and related units total 32,458 units. Each dividend equivalent unit is economically equal to one share of Synchrony Financial common stock and will vest, settle, and expire on the same terms as the related restricted stock units.

Rhea-AI Summary

Synchrony Financial director Laurel Richie reported an automatic award of dividend equivalent units linked to existing equity awards. On February 17, 2026, Richie acquired 129 dividend equivalent units at a reference price of $72.3100 per unit.

The units were accrued as dividends on common shares underlying restricted stock units and deferred stock units previously granted under Synchrony’s long-term incentive and non-employee director deferred compensation plans. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock, bringing Richie’s directly held total to 49,884 units after the transaction.

Rhea-AI Summary

Synchrony Financial director Alves Paget Leonard reported an automatic grant of dividend equivalent units. On February 17, 2026, Leonard acquired 147 dividend equivalent units tied to previously granted restricted stock units and deferred stock units under Synchrony’s long-term incentive and non-employee director deferred compensation plans at a reference price of $72.31 per unit.

Each dividend equivalent unit represents the economic value of one share of Synchrony Financial common stock, and Leonard’s holdings in these related units increased to 50,558 following this accrual.

Rhea-AI Summary

Synchrony Financial director Fernando Aguirre reported an automatic acquisition of dividend equivalent units tied to his restricted stock units. On February 17, 2026, he received 14 dividend equivalent units, each economically equal to one share of Synchrony Financial common stock, reflecting dividends paid on the underlying RSUs. His directly held dividend equivalent and related non-derivative holdings now total 28,576 units/shares. He also reports indirect ownership of 15,300 common shares held by family trusts.

Rhea-AI Summary

Synchrony Financial executive Curtis Howse reported an automatic grant of dividend equivalent units. On the dividend payment date, he acquired 208 dividend equivalent units tied to existing restricted stock units, each economically equivalent to one share of Synchrony Financial common stock and vesting on the same schedule as the underlying awards.

Rhea-AI Summary

Synchrony Financial officer receives additional stock-linked units through dividends. On February 17, 2026, Brian J. Wenzel Sr. acquired 287 dividend equivalent units tied to existing restricted stock units, bringing his directly held units and related common stock equivalents to 116,569.

The dividend equivalent units were accrued as dividends on common shares underlying restricted stock units and will vest, settle, and expire on the same terms as those restricted stock units. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

DOUBLES BRIAN D reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director and officer Brian D. Doubles reported an automatic award of 1,172 dividend equivalent units on February 17, 2026. These units were credited as dividends on common shares underlying his restricted stock units at a reference value of $72.31 per unit and increase his directly held derivative-equivalent position to 942,058 units. The dividend equivalent units will vest, settle, and expire on the same schedule and terms as the related restricted stock units and are each economically equivalent to one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial officer Darrell Owens reported mixed insider activity. On February 17, 2026, he sold 10,304 shares of common stock in an open-market transaction at $70.60 per share, under a Rule 10b5-1 trading plan adopted on October 17, 2025.

On the same date, he acquired 68 dividend equivalent units at $72.31 per unit, tied to underlying restricted stock units and economically equivalent to common shares. Following these transactions, he directly held 16,233 shares of common stock and 26,537 dividend equivalent units.